Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting
- 1 January 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9150) , 359-363
- https://doi.org/10.1016/s0140-6736(98)06318-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Food and Drug Administration Conference on the Feasibility of Genetic Technology to Close the HIV Window in Donor ScreeningTransfusion, 1997
- A search for hepatitis C virus polymerase chain reaction-positive but seronegative subjects among blood donors with elevated alanine aminotransferaseTransfusion, 1997
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United StatesNew England Journal of Medicine, 1995
- Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor StudyTransfusion, 1995
- Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.Genome Research, 1995
- Quantification of Hepatitis C Virus RNA by Competitive Reverse Transcription and Polymerase Chain Reaction Using a Modified Hepatitis C Virus RNA TranscriptAnalytical Biochemistry, 1995
- Hepatitis C Virus Replication during Acute Infection in the ChimpanzeeThe Journal of Infectious Diseases, 1992
- A Long-Term Study of Hepatitis C Virus Replication in Non-A, Non-B HepatitisNew England Journal of Medicine, 1991
- Avoiding false positives with PCRNature, 1989